Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,121 | -60,177 | -187,865 | -125,311 | -69,332 |
| Depreciation Amortization | 513 | -79 | 4,975 | 4,408 | 3,266 |
| Income taxes - deferred | N/A | N/A | 4,341 | 0 | N/A |
| Accounts receivable | -2,011 | -1,353 | 8,970 | 7,142 | 6,946 |
| Accounts payable and accrued liabilities | 6,523 | 13 | 1,380 | 3,696 | -3,723 |
| Other Working Capital | -7,784 | -2,335 | 19,242 | 13,755 | -1,112 |
| Other Operating Activity | 18,017 | 13,263 | 31,476 | 15,657 | 8,615 |
| Operating Cash Flow | $-111,863 | $-50,668 | $-117,481 | $-80,653 | $-55,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,546 | -927 | -1,653 | -970 | -601 |
| Purchase Of Investment | -91,614 | -64,140 | -299,182 | -234,191 | -152,213 |
| Sale Of Investment | 193,600 | 97,500 | 200,842 | 132,695 | 63,479 |
| Investing Cash Flow | $100,440 | $32,433 | $-99,993 | $-102,466 | $-89,335 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,278 | 21,266 | 159,218 | 135,524 | 116,690 |
| Other Financing Activity | 0 | 0 | -7,786 | -7,786 | -7,786 |
| Financing Cash Flow | $23,278 | $21,266 | $151,432 | $127,738 | $108,904 |
| Exchange Rate Effect | -144 | 26 | -244 | -271 | -26 |
| Beginning Cash Position | 117,512 | 117,512 | 183,798 | 183,798 | 183,798 |
| End Cash Position | 129,223 | 120,569 | 117,512 | 128,146 | 148,001 |
| Net Cash Flow | $11,711 | $3,057 | $-66,286 | $-55,652 | $-35,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,863 | -50,668 | -117,481 | -80,653 | -55,340 |
| Capital Expenditure | -1,546 | -927 | -1,653 | -970 | -601 |
| Free Cash Flow | -113,409 | -51,595 | -119,134 | -81,623 | -55,941 |